Chen et al.s study on the circLPAR3/miR-513b-5p/JPT1 axis promoting glycolysis and radioresistance provides direct evidence for LPA pathway involvement in radioresistance (49)
The practical rule: use a U-100 syringe for semaglutide, tirzepatide, and similar compounded peptides reconstituted at 1 mg/ml
The products are MEDICALLY MINDED Hand Sanitizer Gel from Plasticos Las Palmas, S.A
Why DSIP Was in Category 2 The FDA placed Emideltide (DSIP) in Category 2 of the 503A bulk drug substances list the category reserved for substances that "raise significant safety concerns." While specific details of the FDA's rationale are not always publicly elaborated, Category 2 placement typically reflects concerns about one or more of the following: Limited human safety data in US regulatory standards Concerns about compounding quality control for peptide formulations Potential for misuse or off-label application without adequate medical supervision Insufficient characterization of dose-response relationships The practical effect of Category 2 placement was that compounding pharmacies could not legally prepare DSIP formulations for patients, effectively cutting off access for the patients who relied on it most
NAD+ infusions are designed to rejuvenate cells and promote optimal functioning at the cellular level
Instead, it reveals two distinct approaches to the same problem, each with advantages in specific contexts
